Cardiac Telerehabilitation Versus In-person After Acute Coronary Syndrome
- Conditions
- Acute Myocardial Infarction (AMI)Cardiac Rehabilitation
- Registration Number
- NCT06807658
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Brief Summary
The purpose of this trial is to evaluate wether a cardiac Telerehabilitation programme is as effective as an in-person rehabilitation program after acute coronary syndrome in the control of cardiovascular risk factors
- Detailed Description
The purpose of this trial is to evaluate wether a cardiac Telerehabilitation programme is as effective as an in-person rehabilitation program after acute coronary syndrome in the control of cardiovascular risk factors via the following variables: % patients with a positive result in the composite variable integrating different targets for secondary prevention in cardiovascular disease and lifestyle habits; Adherence to cardiac rehabilitation program; Adherence to pharmacological treatment; Quality of Life improvement ; Anxiety and depression; Satisfaction rate; Functional capacity; Cardiac cause hospitalization; Emergency visits; and Angioplasty revascularization procedure.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 129
- Acute myocardial infarct prior to 2 months
- Killip I-II classification
- No previous myocardial infarction
- No angina pectoris
- No ischemia in complementary explorations
- Normal arterial pressure response during stress test.
- No relevant arrythmias
- Left ventricular ejection fraction >= 35%
- Functional capacity >5 METS
- Signing of the inform consent
- Physical or intellectual disability that prevents patients from enrolling in a cardiac rehabilitation program
- Impossibility for digital media use
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method % patients with a positive result in the composite variable integrating different targets for secondary prevention in cardiovascular disease and lifestyle habits • (%) [Time Frame: 0-2months +- 30 days-6 months +-7days] Variable for Cardiovascular Risk Factor Control: Composite Variable Integrating Different Targets for Secondary Prevention in Cardiovascular Disease and Lifestyle Habits
1. Blood pressure \<140/90 mmHg
2. Maintaining normal weight or a 5% reduction in body weight if BMI \> 25 kg/m2
3. Abdominal circumference \<88 cm in women and \<102 cm in men
4. LDL \<50 mg/dl and a reduction of \>50% in initial LDL levels
5. Smoking cessation
6. Adherence to a heart-healthy diet (PREDIMED Questionnaire\* ≥7)
7. Adherence to physical activity level: 6,000-10,000 steps/day or moderate-high IPAQ\*\* result (International Physical Activity Questionnaire)
- Secondary Outcome Measures
Name Time Method Adherence to cardiac rehabilitation program 2 months +-30 day % of patients adherent to cardiac rehabilitation program
Adherence to pharmacological treatment 0-2months +- 30 days-6 months +-7days Adherence to pharmacological treatment by Morinsky Green Questionnaire, Dichotomous variable: yes means adherent to treatment wich is a better score and no means non adherent to treatment wich is a worse score.
Quality of Life improvement 0-2months +- 30 days-6 months +-7days Quality of Life by EuroQol-5D questionnaire. EuroQoL-5D index (0-1) 0: Represent the worse state of Health, equivalent to death.
1: Represents the best state of Health ( no problems in any dimension of the questionnaire).Anxiety and depression 0-2months +- 30 days-6 months +-7days Anxiety and depression by Hospital Anxiety and Depression Scale (HADS). HAD Questionnaire:
0-42: Higher values are worse than lower values.Satisfaction rate 2months +- 30 days Satisfaction rate with the program, Scale 0-100 (%); 0-100%: Higher values are better than lower values
Functional capacity 0-2months +- 30 days Functional capacity by cardiac stress test (METS)
Cardiac cause hospitalization 6 months +-7days Cardiac cause hospitalization
Emergency visits 6 months +-7days Emergency visits
Angioplasty revascularization procedure 0-2months +- 30 days Angioplasty revascularization procedure. Further coronary angiography during follow up Yes: is worse No: is better
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Germans Trias i Pujol University Hospital
🇪🇸Badalona, Spain
Germans Trias i Pujol University Hospital🇪🇸Badalona, Spain